Lourdes Mengual
Papers
1
Total Citations
2
H-Index
1
About
Dr. Lourdes Mengual is a leading researcher in urologic oncology, with a primary focus on liquid biopsy and its applications in prostate cancer management. Her work centers on improving the prediction of disease recurrence after radical prostatectomy, a critical challenge in localized prostate cancer. Dr. Mengual’s major contributions include pioneering the use of circulating cell-free DNA (cfDNA) as a non-invasive biomarker to enhance prognostic accuracy beyond traditional clinicopathological parameters. Her 2024 study on the role of liquid biopsy in progressive PSA patients after radical prostatectomy, though early in its citation impact, addresses a pressing clinical need by evaluating cfDNA levels to better stratify patients at risk of recurrence. This work builds on her broader expertise in developing molecular tools for cancer detection and monitoring. With a growing citation footprint, Dr. Mengual’s research is shaping the future of personalized oncology, offering the potential to reduce overtreatment and improve outcomes for prostate cancer patients. Her innovative approach to liquid biopsy positions her as a key figure in translating molecular biology into practical clinical tools.
Research Focus
Key Achievements
Top Papers
- 1